HepatoBiliary and Pancreatic Oncology Group Profile
HepatoBiliary and Pancreatic Oncology Group

@HPBO_team

Followers
251
Following
60
Media
10
Statuses
32

Settled at the Wolfson Wohl Cancer Research Centre (WWCRC, University of Glasgow) we are committed to study Cholangiocarcinoma by patient derived organoids

Joined March 2021
Don't wanna be here? Send us removal request.
@fr_amato
Francesco Amato, PhD
2 years
Just concluding the first session post-lunch about "Personalising the early diagnosis of Biliary Cancer". #ensccaPrecisionBTCNetworkJointmeeting. Amazing talks from @PMRodrigues19 @boulter_lab #ShahidKhan @LewisRobertsMD #ChristophSchramm @PrecisionBTCnet. Insightful discussion!!
0
2
10
@HPBO_team
HepatoBiliary and Pancreatic Oncology Group
3 years
Congratulations to @chiarabraconi for being promoted to Professor at @UofGlasgow @UofGCancerSci. Very well deserved!! Now it is time for celebration!!!
15
3
77
@fr_amato
Francesco Amato, PhD
3 years
Just concluded the basic research seminar session. Three amazing talks from @LewisRobertsMD #moniqueverstegen @ErasmusMC and @BenjaminDwyer4 about the current pre-clinical models for studying cholangiocarcinoma #ccfac2023 @chiarabraconi @vincorbo @curecc
0
4
22
@fr_amato
Francesco Amato, PhD
3 years
Interesting talk from @ColmJJORourke at the #ccfac2023 @curecc about the rapid progressor/long survivor trascriptomic signature in iCCA patients and functional rewiring of myeloid cells in these patients. Cool data! @chiarabraconi @UCPHAndersenLab
0
6
21
@curecc
Cholangiocarcinoma Foundation
3 years
Thank you, @drlauragoff and @chiarabraconi for sharing clinical and scientific 🧪 updates. #curecca #ccfac23 #hopedealers
0
8
17
@HPBO_team
HepatoBiliary and Pancreatic Oncology Group
3 years
First session kicked off by @chiarabraconi excellent and patient friendly presentation talking about disgnosis and models in CCA @curecc
0
6
13
@chiarabraconi
chiara braconi
3 years
Here we are.. CCF23 10th conference is about to start. We will discuss lots of topics all around #cca. Happy to see so many attendees in person and virtually ⁦@curecc⁩ ⁦@CcaEns⁩ ⁦@staclinds⁩ ⁦@drlauragoff
0
13
29
@fr_amato
Francesco Amato, PhD
3 years
Thrilled to be in Salt Lake City attending the CCF conference #ccfac2023 chaired by @chiarabraconi and @drlauragoff. This morning lots of Inspiring stories shared by all the patients that are fighting against this terrible disease. Can't wait for all the talks. @curecc
0
6
17
@Somaieh_Hedayat
Somaieh Hedayat
4 years
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage | Nature Communications
Tweet card summary image
nature.com
Nature Communications - Understanding which patients will respond to FOLFIRINOX therapy is important for clinical outcome. Here, the authors show that the MIR1307 is increased pancreatic cancer...
0
2
3
@chiarabraconi
chiara braconi
4 years
Happy to share our study on @WorldPancreaticCancerDay. Hope for novel biomarkers to guide treatment in pancreatic cancer patients. Congratulations @AgapeOnlusAss @fr_amato @afterlampis Thank you @PancreaticCanUK to support it. @royalmarsdenNHS @ICR_London @UofGMVLS @OrganoidsLab
@UofGCancerSci
UofG Cancer Sciences
4 years
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage @chiarabraconi @fr_amato
5
6
45
@HPBO_team
HepatoBiliary and Pancreatic Oncology Group
4 years
Take a moment to give a look to our latest paper out on @NatureComms! @chiarabraconi , @ColinRae76 @AgapeOnlusAss , @afterlampis , @UofGMVLS , @UofGCancerSci.
@fr_amato
Francesco Amato, PhD
4 years
Our paper is finally out on @NatureComms. Take a moment to give a look. Such an amazing experience to take part to this study. Thanks to all the co-authors, and a a special thanks to @chiarabraconi for the amazing leadership and to @AgapeOnlusAss and @afterlampis.
1
3
6
@CRUK_SI
CRUK Scotland Inst
4 years
📌We are offering a PhD studentship with investigating the Liver Metastatic Niche through developing 3D models in parallel with analysis from preclinical models and human samples. #FindAPhD #PhDposition ⏰Apply by 31st October More details:
1
5
7
@PaulaMorgane
Paula Hoffmeister-Wittmann
5 years
Great talk by Diego Calvisi on animal models of #CCA 🐁🧫! Always inspiring to hear other researchers present their crurent work and progress! @CcaEns @CholangioNet @EASLedu
0
4
23
@HPBO_team
HepatoBiliary and Pancreatic Oncology Group
5 years
Two amazing days of high quality contents and full of extraordinary and illuminating discussions. Hope to see you all soon in person @rirmacias @JesusMBanales @CUBEROlab @chiarabraconi @CCA_Alliance @CcaEns @EASLedu @boulter_lab @UCPHAndersenLab @ColinRae76
0
2
8
@HPBO_team
HepatoBiliary and Pancreatic Oncology Group
5 years
8. Early afternoon was dedicated to the educational session focused on: - Hydrodynamic tail vein injection (Diego Calvisi‘s lab) - Genetic strategies for in vivo modelling (Silve Vicent's lab)
1
0
2
@HPBO_team
HepatoBiliary and Pancreatic Oncology Group
5 years
7. Finally, @rirmacias @hevepharm had the last presentation talking about models to study the therapy resistance in #CCA.
1
0
1
@HPBO_team
HepatoBiliary and Pancreatic Oncology Group
5 years
6. Gianluigi Giannelli (National Institute of Gastroenterology S. de Bellis) talked about #PDX. He showed how to establish #PDX and discussed the crucial aspects in the establishment of PDX.
1
0
1
@HPBO_team
HepatoBiliary and Pancreatic Oncology Group
5 years
5. After the break, Javier Cubero @CUBEROlab had an interesting talk about animal models of #CCA focusing on the models from his lab.
1
0
1
@HPBO_team
HepatoBiliary and Pancreatic Oncology Group
5 years
4. Guido Carpino (Universita' degli studi di Roma Foro Italico) concluded the 1st part with a presentation about the importance of #CCA models resembling the original histomorphology of #cholangiocarcinoma. The talk has then been followed by an active discussion on this topic.
1
0
1